Successful treatment of JMML with related bone marrow transplantation after reduced-intensity conditioning [1]

Bone Marrow Transplantation

Volumn 36, Issue 5, 2005, Pages 453-454

  Koyama, M ^a   Nakano, T ^b   Takeshita, Y ^a   Sakata, A ^a   Sawada, A ^a   Yasui, M ^a   Okamura, T ^a   Inoue, M ^a   Kawa, K ^a  

^a RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

^b KANSAI MEDICAL UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOSPORIN; CYTARABINE; ETOPOSIDE; FLUDARABINE; MELPHALAN; METHYLPREDNISOLONE; MITOXANTRONE; TACROLIMUS; THIOTEPA;

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; CHILD DEVELOPMENT; CLINICAL ARTICLE; GRAFT VERSUS HOST REACTION; HUMAN; JUVENILE MYELOMONOCYTIC LEUKEMIA; LETTER; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MORTALITY; MYELOABLATIVE CONDITIONING; NONMYELOABLATIVE CONDITIONING; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; TREATMENT RESPONSE; WHOLE BODY RADIATION;

BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; MALE; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 30944444600     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705047     Document Type: Letter

References (10)

1. Arico M, Biondi A, Pui CH. Juvenile myelomonocytic leukemia. Blood 1997; 90: 479-488.
2. Smith FO, King R, Nelson G et al. Unrelated donor bone marrow transplantation for children with juvenile myelomonocytic leukaemia. Br J Hematol 2002; 116: 716-724.
3. Locatelli F, Niemeyer C, Angelucci E et al. Allogeneic bone marrow transplantation for chronic myelomonocytic leukemia in childhood: A report from the European working group on myelodysplastic syndrome in childhood. J Clin Oncol 1997; 15: 566-573.
4. Manabe A, Okamura J, Yumura-Yagi K et al. Allogeneic hematopoietic stem cell transplantation for 27 children with juvenile myelomonocytic leukemia diagnosed based on the criteria of the international JMML working group. Leukemia 2002; 16: 645-649.
5. Matthes-Martin S, Mann G, Peters C et al. Allogeneic bone marrow transplantation for juvenile myelomonocytic leukaemia: A single centre experience and review of the literature. Bone Marrow Transplant 2000; 26: 377-382.
6. Korthof ET, Snijder PP, de Graaff AA et al. Allogeneic bone marrow transplantation for juvenile myelomonocytic leukemia: A single center experience of 23 patients. Bone Marrow Transplant 2005; 35: 455-461.
7. Locatelli F, Nollke P, Zecca M et al. Hematopoietic stem cell transplantation(HSCT) in children with juvenile myelomonocytic leukemia (JMML): Results of the EWOG-MDS/EBMT trial. Blood 2005; 105: 410-419.
8. Huma Z, Boulad F, Black P et al. Growth in children after bone marrow transplantation for acute leukemia. Blood 1995; 86: 819-824.
9. Sanders JE, Hawley J, Levy W et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 1996; 87: 3045-3052.
10. Deeg HJ, Socie G. Malignancies after hematopoietic stem cell transplantation: Many questions, some answers. Blood 1998; 91: 1833-1844.